Menu
GeneBe

rs77821631

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_022124.6(CDH23):c.3364T>G(p.Leu1122Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,611,752 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1122F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0068 ( 15 hom., cov: 33)
Exomes 𝑓: 0.00066 ( 9 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 2.56
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
C10orf105 (HGNC:20304): (chromosome 10 open reading frame 105) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005255878).
BP6
Variant 10-71712808-T-G is Benign according to our data. Variant chr10-71712808-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 45917.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=4, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00677 (1032/152350) while in subpopulation AFR AF= 0.0236 (980/41598). AF 95% confidence interval is 0.0223. There are 15 homozygotes in gnomad4. There are 475 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 15 AD,AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CDH23NM_022124.6 linkuse as main transcriptc.3364T>G p.Leu1122Val missense_variant 28/70 ENST00000224721.12
C10orf105NM_001164375.3 linkuse as main transcriptc.*3128A>C 3_prime_UTR_variant 2/2 ENST00000441508.4
CDH23NM_001171930.2 linkuse as main transcriptc.3364T>G p.Leu1122Val missense_variant 28/32
C10orf105NM_001168390.2 linkuse as main transcriptc.*3128A>C 3_prime_UTR_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CDH23ENST00000224721.12 linkuse as main transcriptc.3364T>G p.Leu1122Val missense_variant 28/705 NM_022124.6 P1Q9H251-1
C10orf105ENST00000441508.4 linkuse as main transcriptc.*3128A>C 3_prime_UTR_variant 2/21 NM_001164375.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00675
AC:
1027
AN:
152232
Hom.:
15
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0235
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00670
GnomAD3 exomes
AF:
0.00168
AC:
409
AN:
242938
Hom.:
8
AF XY:
0.00115
AC XY:
152
AN XY:
132348
show subpopulations
Gnomad AFR exome
AF:
0.0247
Gnomad AMR exome
AF:
0.000998
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000334
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000183
Gnomad OTH exome
AF:
0.000845
GnomAD4 exome
AF:
0.000662
AC:
966
AN:
1459402
Hom.:
9
Cov.:
31
AF XY:
0.000517
AC XY:
375
AN XY:
725778
show subpopulations
Gnomad4 AFR exome
AF:
0.0231
Gnomad4 AMR exome
AF:
0.00119
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000933
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000135
Gnomad4 OTH exome
AF:
0.00184
GnomAD4 genome
AF:
0.00677
AC:
1032
AN:
152350
Hom.:
15
Cov.:
33
AF XY:
0.00638
AC XY:
475
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.0236
Gnomad4 AMR
AF:
0.00209
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00664
Alfa
AF:
0.00143
Hom.:
3
Bravo
AF:
0.00711
ESP6500AA
AF:
0.0212
AC:
86
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00206
AC:
249
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 22, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 24, 2019- -
Autosomal recessive nonsyndromic hearing loss 12 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineDec 17, 2010Leu1122Val in exon 28 of CDH23: This variant has been reported in 5/50 (10%) of control chromosomes from the Black population in dbSNP (rs77821631). In addition , this residue is not highly conserved across species. Of note, most other speci es have a valine at this position. In summary, this variant is not expected to h ave clinical significance. -
Usher syndrome type 1D Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Usher syndrome type 1 Benign:1
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Dec 03, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
Cadd
Benign
7.9
Dann
Benign
0.89
DEOGEN2
Benign
0.0070
T;T;T;T;.
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.45
T;T;T;T;T
MetaRNN
Benign
0.0053
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D;D;N
PrimateAI
Benign
0.41
T
Sift4G
Benign
1.0
T;T;.;T;.
Polyphen
0.0
.;.;B;.;.
Vest4
0.18
MVP
0.76
ClinPred
0.0035
T
GERP RS
4.9
Varity_R
0.059
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77821631; hg19: chr10-73472565; API